Stocks / NASDAQ / Cytosorbents Corporation

Cytosorbents Corporation

Our Opinion

Cytosorbents Corporation is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical products, services, research and therapies.

Supporting Evidence:

CytoSorbents Awarded $650,000 in SBIR Grant Contracts to Continue Development of Novel Hemocompatible Potassium Binding Polymers

“CytoSorbents is collaborating with leading military researchers to optimize prototype polymers capable of rapidly reducing serum potassium in large animal models, using simple “blood in, blood out” hemoperfusion systems and other strategies. “

Company Description

CytoSorbents Corp. is a critical care immunotherapy company, which engages in blood purification to control deadly inflammation in critically-ill and cardiac surgery patients. Its products include cytosorb, contrastsorb, vetresq, hemodefend, and drugsorb. The company was founded by Joseph Rubin on April 25, 2002 and is headquartered in Monmouth Junction, NJ. [Source: MarketWatch]

Company Website: